ACHL News and Press, Achilles Therapeutics plc From 11/09/21

- Oral Presentation at European Society for Gene and Cell Therapy (ESGCT) demonstrated ability to generate potent anti-cancer cell therapy candidates in multiple solid tumor types - - Society for Immunotherapy of Cancer (SITC) abstracts highlight the ability to detect, quantify and tr...

LONDON, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today delivered an oral presentation (OR54) at the 2021 European Society for Gene and Cell Therapy (ESG...

LONDON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that it has joined the Northern Alliance for Advanced Therapies Treatment Centre (NA-AT...

Gainers: QTRX +18.5%. PROG +3.7%. MTTR +2.6%. KC +2.5%. LFMD +2.2%. Losers: RLAY -8.9%. HX -6.2%. ACHL -3.4%. STLD -2.0%. ARRY -1.9%. For further details see: QTRX, PROG, RLAY and HX among after hours movers

Baker Brothers’ 13F portfolio value decreased from $23.07B to $22.77B this quarter. The InVitae stake was reduced this quarter while increasing Apellis Pharma and Heron Therapeutics. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almo...

LONDON, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, will present an oral presentation at the 2021 European Society for Gene and Cell Therapy (ESGCT) Congre...

Gainers: Alzamend Neuro (NASDAQ:ALZN) +44%. Farmmi (NASDAQ:FAMI) +31%. Paltalk (NASDAQ:PALT) +29%. Onion Global (NYSE:OG) +27%. Progenity (NASDAQ:PROG) +23%. China Online Education (NYSE:COE) +17%. Meten Holding (NASDAQ:METX) +16%. Achilles Therapeutics (NASDAQ:ACHL) +13%. Crown Ele...

Puhui Wealth Investment (NASDAQ:PHCF) +55%. Red Cat Holdings RCAT +50% after subsidiary receives five-year contract with NASA Paltalk (NASDAQ:PALT) +36%. Vinco Ventures (NASDAQ:BBIG) +16%. VIZIO Holding (NYSE:VZIO) +10%. U.S. Energy (NASDAQ:USEG) +8%. Syndax Pharmaceuticals (NASDAQ:...

LONDON, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that management will present at the following investor conferences in September. ...

LONDON, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that US patent US 11,098,121 and European patent EP3347039B have been granted. The pate...